Cargando…
Adlercreutzia equolifaciens Is an Anti-Inflammatory Commensal Bacterium with Decreased Abundance in Gut Microbiota of Patients with Metabolic Liver Disease
Non-alcoholic fatty liver disease (NAFLD) affects about 20–40% of the adult population in high-income countries and is now a leading indication for liver transplantation and can lead to hepatocellular carcinoma. The link between gut microbiota dysbiosis and NAFLD is now clearly established. Through...
Autores principales: | Oñate, Florian Plaza, Chamignon, Célia, Burz, Sebastian D., Lapaque, Nicolas, Monnoye, Magali, Philippe, Catherine, Bredel, Maxime, Chêne, Laurent, Farin, William, Paillarse, Jean-Michel, Boursier, Jérome, Ratziu, Vlad, Mousset, Pierre-Yves, Doré, Joël, Gérard, Philippe, Blottière, Hervé M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418321/ https://www.ncbi.nlm.nih.gov/pubmed/37569608 http://dx.doi.org/10.3390/ijms241512232 |
Ejemplares similares
-
Fecal Microbiota Transplant from Human to Mice Gives Insights into the Role of the Gut Microbiota in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Burz, Sebastian D., et al.
Publicado: (2021) -
Heterologous expression of equol biosynthesis genes from Adlercreutzia equolifaciens
por: Vázquez, Lucía, et al.
Publicado: (2021) -
Complete Genome Sequence of the Equol-Producing Bacterium Adlercreutzia equolifaciens DSM 19450(T)
por: Toh, Hidehiro, et al.
Publicado: (2013) -
Complete Genome Sequence of Adlercreutzia equolifaciens subsp. celatus DSM 18785
por: Takahashi, Haruno, et al.
Publicado: (2021) -
Transcriptional Regulation of the Equol Biosynthesis Gene Cluster in Adlercreutzia equolifaciens DSM19450(T)
por: Flórez, Ana Belén, et al.
Publicado: (2019)